• Je něco špatně v tomto záznamu ?

Tick-borne encephalitis virus modulates sphingolipid and phospholipid metabolism in infected human neuronal cells

P. Šimečková, J. Slavík, A. Fořtová, I. Huvarová, L. Králiková, M. Stefanik, P. Svoboda, D. Ruzek, M. Machala

. 2024 ; 26 (4) : 105303. [pub] 20240124

Jazyk angličtina Země Francie

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc24014185

The life cycle of enveloped viruses is closely linked to host-cell lipids. However, changes in lipid metabolism during infections with the tick-borne encephalitis virus (TBEV) have not been described. TBEV is a medically important orthoflavivirus, which is endemic to many parts of Europe and Asia. In the present study, we performed targeted lipidomics with HPLC-MS/MS to evaluate changes in phospholipid and sphingolipid concentrations in TBEV-infected human neuronal SK-N-SH cells. TBEV infections significantly increased phosphatidylcholine, phosphatidylinositol, and phosphatidylserine levels within 48 h post-infection (hpi). Sphingolipids were slightly increased in dihydroceramides within 24 hpi. Later, at 48 hpi, the contents of sphinganine, dihydroceramides, ceramides, glucosylceramides, and ganglioside GD3 were elevated. On the other hand, sphingosine-1-phosphate content was slightly reduced in TBEV-infected cells. Changes in sphingolipid concentrations were accompanied by suppressed expression of a majority of the genes linked to sphingolipid and glycosphingolipid metabolism. Furthermore, we found that a pharmacological inhibitor of sphingolipid synthesis, fenretinide (4-HPR), inhibited TBEV infections in SK-N-SH cells. Taken together, our results suggested that both structural and signaling functions of lipids could be affected during TBEV infections. These changes might be connected to virus propagation and/or host-cell defense.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc24014185
003      
CZ-PrNML
005      
20240911160745.0
007      
ta
008      
240725s2024 fr f 000 0|eng||
009      
AR
024    7_
$a 10.1016/j.micinf.2024.105303 $2 doi
035    __
$a (PubMed)38272253
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a fr
100    1_
$a Šimečková, Pavlína $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
245    10
$a Tick-borne encephalitis virus modulates sphingolipid and phospholipid metabolism in infected human neuronal cells / $c P. Šimečková, J. Slavík, A. Fořtová, I. Huvarová, L. Králiková, M. Stefanik, P. Svoboda, D. Ruzek, M. Machala
520    9_
$a The life cycle of enveloped viruses is closely linked to host-cell lipids. However, changes in lipid metabolism during infections with the tick-borne encephalitis virus (TBEV) have not been described. TBEV is a medically important orthoflavivirus, which is endemic to many parts of Europe and Asia. In the present study, we performed targeted lipidomics with HPLC-MS/MS to evaluate changes in phospholipid and sphingolipid concentrations in TBEV-infected human neuronal SK-N-SH cells. TBEV infections significantly increased phosphatidylcholine, phosphatidylinositol, and phosphatidylserine levels within 48 h post-infection (hpi). Sphingolipids were slightly increased in dihydroceramides within 24 hpi. Later, at 48 hpi, the contents of sphinganine, dihydroceramides, ceramides, glucosylceramides, and ganglioside GD3 were elevated. On the other hand, sphingosine-1-phosphate content was slightly reduced in TBEV-infected cells. Changes in sphingolipid concentrations were accompanied by suppressed expression of a majority of the genes linked to sphingolipid and glycosphingolipid metabolism. Furthermore, we found that a pharmacological inhibitor of sphingolipid synthesis, fenretinide (4-HPR), inhibited TBEV infections in SK-N-SH cells. Taken together, our results suggested that both structural and signaling functions of lipids could be affected during TBEV infections. These changes might be connected to virus propagation and/or host-cell defense.
650    _2
$a lidé $7 D006801
650    12
$a sfingolipidy $x metabolismus $7 D013107
650    12
$a viry klíšťové encefalitidy $x fyziologie $7 D004669
650    12
$a neurony $x virologie $x metabolismus $7 D009474
650    12
$a fosfolipidy $x metabolismus $7 D010743
650    _2
$a metabolismus lipidů $7 D050356
650    _2
$a buněčné linie $7 D002460
650    _2
$a lipidomika $7 D000081362
650    _2
$a tandemová hmotnostní spektrometrie $7 D053719
650    _2
$a interakce hostitele a patogenu $7 D054884
655    _2
$a časopisecké články $7 D016428
700    1_
$a Slavík, Josef $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Fořtová, Andrea $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Huvarová, Ivana $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Králiková, Lucie $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
700    1_
$a Stefanik, Michal $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Brno, Czech Republic; Department of Chemistry and Biochemistry, Mendel University, Brno, Czech Republic
700    1_
$a Svoboda, Pavel $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Science, České Budějovice, Czech Republic; Faculty of Veterinary Medicine, University of Veterinary Sciences Brno, Brno, Czech Republic
700    1_
$a Růžek, Daniel, $d 1981- $u Laboratory of Emerging Viral Diseases, Veterinary Research Institute, Brno, Czech Republic; Institute of Parasitology, Biology Centre of the Czech Academy of Science, České Budějovice, Czech Republic; Department of Experimental Biology, Faculty of Science, Masaryk University, Brno, Czech Republic. Electronic address: ruzekd@paru.cas.cz $7 stk2008441707
700    1_
$a Machala, Miroslav $u Department of Pharmacology and Toxicology, Veterinary Research Institute, Brno, Czech Republic
773    0_
$w MED00006000 $t Microbes and infection $x 1769-714X $g Roč. 26, č. 4 (2024), s. 105303
856    41
$u https://pubmed.ncbi.nlm.nih.gov/38272253 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20240725 $b ABA008
991    __
$a 20240911160740 $b ABA008
999    __
$a ok $b bmc $g 2143774 $s 1226051
BAS    __
$a 3
BAS    __
$a PreBMC-MEDLINE
BMC    __
$a 2024 $b 26 $c 4 $d 105303 $e 20240124 $i 1769-714X $m Microbes and infection $n Microbes Infect $x MED00006000
LZP    __
$a Pubmed-20240725

Najít záznam

Citační ukazatele

Možnosti archivace